FDMT·35104E100·US·equity·Healthcare - Biotechnology-13D/G
FDMT (4D MOLECULAR THERAPEUTICS IN) is held by 87 institutional investors as of Q1 2026. Largest holders: JANUS HENDERSON GROUP PLC ($48.9M), RA CAPITAL MANAGEMENT, L.P. ($47M), GOLDMAN SACHS GROUP INC ($39.2M). Net institutional sentiment: Mixed.
See how FDMT's score breaks down across 4 SEC sources
Showing 1-20 of 98
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer